https://www.avient.com/sites/default/files/2024-03/Terms and Conditions of Sale for South Africa.pdf
Personal Information' means information
relating to any person, including but not limited to: (i) information
relating to the race, gender, sex, pregnancy, marital status, national,
ethnic or social origin, colour, sexual orientation, age, physical or
mental health, well-being, disability, religion, conscience, belief,
culture, language and birth of the person; (ii) information relating to
the education or the medical, financial, criminal or employment
history of the person; (iii) information relating to the financial affairs
of the person; (iv) credit card details and transactional data; (v) any
identifying number, symbol, e-mail address, physical address,
telephone number or other particular assignment to the person; (vi)
biometric information about a person; (v) personal opinions, views
and preferences of a person; (vii) correspondence sent by the person
that is implicitly or explicitly of a private or confidential nature or
further correspondence that would reveal the contents of the original
correspondence; (viii) the views or opinions of another individual
about the person; (ix) the name of the person if it appears with other
personal information relating to the person or if the disclosure of the
name itself would reveal information about the person; and (x) any
other information which may be treated or defined as "personal
information" in terms of any applicable laws, including Data
Protection Legislation.
https://www.avient.com/sites/default/files/AVNT February IR Presentation_w_Non-GAAP Recs.pdf
PY
( T O TA L C O M PA N Y )
$790
$719
2022 2023
$107
$114
2022 2023
Sales Adjusted EBITDA
(in millions)
$0.42
$0.52
2022 2023
Adjusted EPS
(in millions)
- 9% + 7% + 24%
Sales Adjusted EBITDA Adjusted EPS
15
Q4 2023 SEGMENT PERFORMANCE
16
CAI
$491
$459
Sales
(in millions)
$70
$84
EBITDA
SEM
$301
$260
Sales
$55
$49
EBITDA
- 7% - 14%+20% - 11%
2022 2023
(in millions)
Q4 EBITDA BRIDGE
( T O TA L C O M PA N Y )
17
$ millions
CAI:
Price / Mix 11
Deflation 14
SEM:
Price / Mix 4
Deflation 9
Net Price Benefit 38
Cost Reductions 13
Wage Inflation (8)
Other (2)
Q4 2023 $114
Adjusted
EBITDA
Q4 2022 $ 107
Demand (34) • Demand was down, but less than in previous
quarters, due to slowing pace of destocking
• Positive net price benefit:
o CAI – Pricing flat with favorable mix from
uptick in packaging and consumer end
markets and raw material deflation
o SEM - Pricing flat with favorable mix from
Composites and raw material deflation
• Cost reductions primarily driven by reduced
administrative costs and cost synergies
2 0 2 4 G U I D A N C E
2024 GUIDANCE
Full Year 2024 Guidance
Adjusted EBITDA $505 to $535 million
Adjusted EPS $2.40 to $2.65
Interest Expense $105 to $110 million
Adjusted Effective Tax Rate 23% to 25%
Capital Expenditures ~$140 million
19
Q1 Adjusted EPS of $0.68
A P P E N D I X
21
Performance
Additives
15%
Pigments
13%
TiO2
9%
Dyestuffs
2%
Polyethylene
10%Nylon
5%
Polypropylene
4%
Styrenic Block
Copolymer
4%
Other Raw
Materials
38%
~40% hydrocarbon based
(Grey shaded materials are hydrocarbon based,
includes portion of “Other Raw Materials”)
Non-hydrocarbon
based materials
RA W MATERIAL BASKET
SEGMENT DATA
U.S. & Canada
41%
EMEA
36%
Asia
18%
Latin America
5%
2023 SEGMENT, END MARKET AND GEOGRAPHY
GEOGRAPHY REVENUESEGMENT FINANCIALS
Consumer
19%
Packaging
23%Industrial
16%
Building and
Construction
9%
Telecommunications
4%
Energy
5%
Defense
7%
END MARKET REVENUE
$2,007M $358M
$1,138M $224M
Sales EBITDA
Specialty Engineered Materials
Color Additives and Inks
$502M$3,143M
(1)
Transportation
10%
Healthcare
7%
23
(1) Total company sales and adjusted EBITDA of $3,143M and $502M, respectively, include intercompany sales eliminations and corporate costs
2 0 2 3 R E V E N U E | $ 2 . 0 B I L L I O N
US & Canada
34%
EMEA
37%
Asia
21%
Latin America
8%
END MARKET REGION
24
Packaging
34%
Consumer
21%
Healthcare
8%
Industrial
15%
Transportation
9%
Building &
Construction
10%
Telecommunications
1% Energy
2%
COLOR, ADDITIVES & INKS
2 0 2 3 R E V E N U E | $ 1 . 1 B I L L I O N
US & Canada
52%
EMEA
35%
Asia
13%
25
Packaging
5%
Consumer
16%
Healthcare
6%Industrial
16%
Transportation
12%
Telecommunications
9%
Energy
10% Defense
18%
Building &
Construction
8%
END MARKET REGION
SPECIALTY ENGINEERED MATERIALS
Packaging
32%
Consumer
26%
Healthcare
9%
Industrial
13%
Building &
Construction
6%
Telecommunications
2%
Energy
2% Defense
1%
Asia
(18% of sales)
Transportation
9%
2 0 2 3 AV I E N T R E G I O N A L S A L E S
Packaging
25%
Consumer
13%
Healthcare
5%
Industrial
18%
Building &
Construction
9%
Energy
5%
Defense
8%
EMEA
(36% of sales)Transportation
13%
Packaging
13%
Consumer
22%
Healthcare
10%
Industrial
16%
Building &
Construction
12%
Energy
6%
Defense
8%
US &
Canada
(41% of sales)
Transportation
9%
Packaging
59%
Consumer
22%
Healthcare
2%
Industrial
8%
Building &
Construction
4%
LATAM
(5% of sales)
Transportation
5%
Telecommunications
4%
Telecommunications
4%
26
B Y E N D M A R K E T
Reconciliation of Non-GAAP Financial Measures
(Unaudited)
(Dollars in millions, except for per share data)
Senior management uses comparisons of adjusted net income from continuing operations attributable to Avient shareholders
and diluted adjusted earnings per share (EPS) from continuing operations attributable to Avient shareholders, excluding special
items, to assess performance and facilitate comparability of results.
https://www.avient.com/sites/default/files/2020-03/2020proxy.pdf
a) Section 5 Section 9
(b)
(c)
(d) Section 8
(e)
(i)
Person
Outstanding
Company Voting Securities
(ii)
Incumbent Board
(iii)
Business Combination
(iv)
(f)
(g)
Section 12
(h)
(i)
Section 13
(j)
Section 10
Section 10
(k)
(l)
(m)
(n)
(o)
Section 5 Section 9
(p)
(q)
(r)
(s)
(t)
(u)
Section 4 Section 9
(v)
(w)
Section 8
(x)
Section 8
(y) Section 8
(z)
(aa)
(bb) Section 6
Section 9
(cc) Section 7 Section 9
(dd)
Section 7 Section 9
(ee)
(ff)
(gg)
Section 5 Section 9
(hh)
3.
https://www.avient.com/products/engineered-polymer-formulations/chemical-corrosion-resistant-formulations/trilliant-hc-healthcare-thermoplastics
MRI, X-ray and CT Scanner Components
https://www.avient.com/industries/healthcare/medical-devices-equipment/surgical-medical-instruments
Trilliant™ Surgical X-Ray Glasses
https://www.avient.com/products/advanced-composites/continuous-fiber-composite-tape-laminates-and-barstock/polystrand-continuous-fiber-tapes-laminates
Available in rolls of unidirectional tape, as well as X-Ply™ 0˚/90˚ and other multi-ply laminates, Polystrand materials can be post-formed and co-molded with mixed materials in thermoforming and injection molding processes to achieve part designs and cycle times that meet the most demanding performance targets.
https://www.avient.com/sites/default/files/2020-10/tpe-injection-molding-guide.pdf
Estimating machine clamp capacity
C = (1.5 to 3) x At
22
Barrel Capacity
If possible, use a machine that utilizes 25% to 75% of the barrel shot size capacity.
https://www.avient.com/sites/default/files/2023-09/Avient Sustainability Day 2023 - Website %289.19%29.pdf
Conventionally-Marketed Products Growth
2017-2022
Sustaina bility-Marketed Products Conventionally-Marketed Products
Sustainably-marketed products account for 1/5 of the market share ... yet deliver 1/3 of growth
9%
4%
CAGR
Source: NY Stern School of Business 2023
MAKING RECYCLABILITY COMMITMENTS
Avient Corporation 26
100% recyclable,
compostable or
reusable packaging
by 2025
35% recycled
content for all plastic
packaging by 2025
30% recycled
content by 2030
100% recyclable,
compostable or reusable
packaging by 2025
20% renewable and
recycled plastics by 2025
100% recyclable,
compostable or reusable
packaging by 2025
To source 100% recycled
or renewable resources
25% recycled content
by 2025
80% of waste recycled
back into Nike products
and other goods by 2025
25% recycled
content by 2025
100% recyclable,
compostable or reusable
packaging by 2025
BRAND-SPECIFIC RECYCLED CONTENT ANNOUNCEMENTS
x …the entire DASANI
product lineup will be
made from
recycled plastic.
https://www.avient.com/sites/default/files/2020-03/polyone-2019-annual-report.pdf
COLLA
B
O
R
A
T
IO
N
INNOVATIO
N
E
X
C
E
L
L
E
N
CE
CORE
VALUES
IN
TE
G
R
IT
Y
HONESTY
R
E
S
P
E
C
T
PERSONAL
VALUES
74424.indd intro_5 3/16/20 12:25 PM
1 Annual Report | 2019
Sustainability In Action: People, Products,
Planet, Performance
Dear PolyOne Shareholders,
2019 was a pivotal, transformational and telling year for our
great company.
https://www.avient.com/products/thermoplastic-elastomers/tpe-knowledge-center/injection-molding-guide/injection-molding-mold-design
Spiral flow tests performed using 0.0625" thick x 0.375" wide channel at 400°F.
Colorant Chromatics™ X-Ray Opaque Formulations